Company Overview of Philogen S.p.A.
Philogen S.p.A., a biotechnology company, is engaged in the discovery and development of biopharmaceutical products for the treatment of certain diseases that are characterized by angiogenesis, the proliferation of newly formed blood vessels. The company focuses on delivering bioactive agents, such as cytokines, radionuclides, or drugs to the site of disease using antibodies and ligands that specifically target stromal antigens. It develops anti-cancer antibody derivatives and antibody-derivatives for the treatment of rheumatoid arthritis. Its products include DARLEUKIN (L19-IL2), Teleukin, and Fibromun (L19-TNF) that are human vascular targeting immunocytokine. The company also develops L19...
Via Bellaria, 35
Sovicille, SI 53018
Founded in 1996
Key Executives for Philogen S.p.A.
Co-Founder, Chief Executive Officer, President and Director
Co-Founder, Director of IP & Licensing and Director
Co-Founder, President of the Scientific Advisory Board and Director
Vice President and Director
Compensation as of Fiscal Year 2014.
Philogen S.p.A. Key Developments
Philogen S.p.A. Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Philogen S.p.A. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries